FABBRONI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 70
EU - Europa 53
AS - Asia 48
OC - Oceania 1
Totale 172
Nazione #
US - Stati Uniti d'America 70
CN - Cina 39
IT - Italia 32
FR - Francia 5
GB - Regno Unito 5
DE - Germania 4
AE - Emirati Arabi Uniti 3
NL - Olanda 3
SG - Singapore 2
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
ID - Indonesia 1
IE - Irlanda 1
IN - India 1
NO - Norvegia 1
TR - Turchia 1
Totale 172
Città #
Beijing 21
Milan 14
Fairfield 8
Ashburn 7
Santa Cruz 4
Chicago 3
Seattle 3
Bari 2
Boardman 2
Buffalo 2
Cambridge 2
Columbus 2
Houston 2
New York 2
Rho 2
Southend 2
Turi 2
Woodbridge 2
Alpharetta 1
Amsterdam 1
Ankara 1
Bandung 1
Basking Ridge 1
Bournemouth 1
Canberra 1
Central District 1
Cernusco sul Naviglio 1
Council Bluffs 1
Dublin 1
Edinburgh 1
Frankfurt am Main 1
Genoa 1
Kleppesto 1
Lake Worth 1
Las Vegas 1
Leiden 1
Les Pavillons-sous-Bois 1
Los Angeles 1
Matera 1
Medford 1
New Delhi 1
Oakland 1
Padova 1
Parabiago 1
Pedrengo 1
Phoenix 1
Portland 1
Vienna 1
Totale 112
Nome #
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers, file dfa8b9a5-5f5d-748b-e053-3a05fe0a3a96 69
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma, file dfa8b9a9-d648-748b-e053-3a05fe0a3a96 51
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin, file dfa8b9aa-5234-748b-e053-3a05fe0a3a96 44
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study, file 0878945f-47ee-40d3-8c0a-1036ac49847f 4
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles, file dfa8b99d-4531-748b-e053-3a05fe0a3a96 4
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives, file dfa8b99e-f2c0-748b-e053-3a05fe0a3a96 2
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors, file dfa8b9a5-81b6-748b-e053-3a05fe0a3a96 1
Totale 175
Categoria #
all - tutte 513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 2 0 0 0 0 0 0 0
2020/202118 0 0 0 0 0 0 11 1 0 1 3 2
2021/202223 0 2 3 0 1 1 3 0 2 1 7 3
2022/202351 3 1 6 8 2 6 6 2 8 1 8 0
2023/202477 2 3 3 8 1 1 33 9 11 6 0 0
Totale 175